medigraphic.com

2017, Number 1

<< Back Next >>

Rev Med MD 2017; 8.9 (1)

Cavitary Retinoblastoma: A Case Report

González-Pérez G, Robles-Yeme D, Muñoz-Solórzano B

Language: Spanish
References: 13
Page: 77-80
PDF size: 731.00 Kb.


ABSTRACT

Retinoblastoma is a potentially fatal malignant intraocular neoplasm, occurring predominantly during infancy. Rarely, it manifests with ophthalmoscopically visible cavities inside the tumor, describing it as cavitary retinoblastoma, which presents chemoresistence and radioresistance, as well as a more favorable prognosis in most cases. We present a clinical case with a diagnosis of cavitary retinoblastoma and its presentation as well as response to treatment. More studies and guides are needed to focus the approach and relapse rates.


REFERENCES

  1. Palamar M, Pirondini C, Shields CL, Shields JA. Cavitary Retinoblastoma: Ultrasonographic and Fluorescein Angiographic Findings in 3 Cases. Arch. Ophthalmol. 2008;126(11):1598-1600.

  2. Soliman S, Eldomiaty W, et al. Clinical presentation of retinoblastoma. A step towards earlier diagnosis. Saudi J Ophthalmol. 2017.

  3. Cassoux N, Lumbroso L, Levy-Gabriel C, et al. Retinoblastoma: Update on current management. Asia Pac J Ophthalmol(Phila). 2017;6:290-295.

  4. Mashayekhi A, Shields C, Eagle R, Shields J. Cavitary changesin retinoblastoma: relations hipto chemoresistance. Ophthalmology 2005;112(6):1145-1150.

  5. Samuels B, Fuchs A.Clinical Pathology of the Eye: A Practical Treatise of Histopathology. New York, NY Hoeber1952;43- 44.

  6. Chaudhry S, Onadim Z, et al. The recognition of cavitary retinoblastoma tumors, Implication for management and genetic analysis. Retina, The Journal of retinal and vitreous diseases. 2017;0:1-6.

  7. Fuller T, Alvi R, Shields C. Optical Coherence Tomography of Cavitary Retinoblastoma. JAMA Ophthalmol. 2016;134(5).

  8. Shields J, Shields C, Meadows A. Chemoreduction in the management ofretinoblastoma.Am J Ophthalmol. 2005;140(3):505-506.

  9. Rojanaporn D, Kaliki S, Bianciotto C, Iturralde J, Say E, Shields C. Intravenous Chemoreduction or Intra-arterial Chemotherapy for Cavitary Retinoblastoma. Long-term Results. Arch Ophthalmol. 2012;130(5):585-590.

  10. 10.Fabian I, Naeem Z, et al. Longterm visual acuity, strabismus and nystagmus outcomes following multimodality treatment in group D Retinoblastoma eyes. Am J Ophthalmol. 2017.

  11. 11.Shields C, Mashayekhi A, Cater J, Shelil A, Meadows A, Shields J. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138(3):329-337.

  12. 12.Mashayekhi A, Shields C, et al. Cavitary changes in retinoblastoma: relationship to chemoresistance. Ophthalmology. 2005;112(6):1145-1150.

  13. 13.Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA. Practical approach to management of retinoblastoma. Arch Ophthalmol. 2004;122(5):729-735.




2020     |     www.medigraphic.com